Purchases and Sales Made in Q2 2022 in Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS) during Q2 2022. The information is specifically focused on institutions that hold shares of Acumen Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-86.8K- 75.69% |
$267K - $424K
|
27.9K
$48K
|
|
|
Aug 15, 2022
Q2 2022
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-88.4K- 14.81% |
$272K - $431K
|
509K
$875K
|
|
|
Aug 15, 2022
Q2 2022
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-145KClosed |
$447K - $709K
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-150K- 81.35% |
$463K - $734K
|
34.5K
$59.3K
|
|
|
Aug 12, 2022
Q2 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-195K- 90.03% |
$599K - $950K
|
21.5K
$37.1K
|
|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-234K- 68.23% |
$720K - $1.14M
|
109K
$187K
|
|
|
Aug 15, 2022
Q2 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-290KClosed |
$892K - $1.41M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-306K- 91.66% |
$943K - $1.49M
|
27.9K
$48K
|
|
|
Aug 12, 2022
Q2 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-599K- 48.51% |
$1.84M - $2.92M
|
636K
$1.09M
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.14M- 29.7% |
$3.51M - $5.55M
|
2.69M
$4.63M
|